When transitioning from semaglutide to another diabetes medication, clinicians should anticipate overlapping drug effects for several weeks
These seem like minor details until you realize you are injecting degraded or inactive product and wondering why nothing is happening
MODY (Maturity-Onset Diabetes of the Young) MODY starts in adolescence or early adulthood and is inheritted in an autosomal dominant way
Semaglutide Not Associated with Increased Risk of Eye Disorders, 19 August 2025, The use of semaglutide medicines and risk of non-arteritic anterior ischemic optic neuropathy (NAION), 27 June 2025, WHO, PRAC concludes eye condition NAION is a very rare side effect of semaglutide medicines Ozempic, Rybelsus and Wegovy, 06 June 2025, European Medicine Agency, Kai-Yang Chen, Hoi-Chun Chan, Chi-Ming Chan, does semaglutide increase the risk of non-arteritic anterior ischemic optic neuropathy